Tert-butyl 4-[4-amino-3-(1H-imidazo[4,5-b]pyridin-6-yl)pyrazolo[3,4-d]pyrimidin-1-yl]piperidine-1-carboxylate;tert-butyl 4-(4-amino-3-iodopyrazolo[3,4-d]pyrimidin-1-yl)piperidine-1-carboxylate;methane;3-methyl-7H-cyclopenta[b]pyridine;1-piperidin-4-yl-3-(1H-pyrrolo[2,3-b]pyridin-5-yl)pyrazolo[3,4-d]pyrimidin-4-amine;2,2,2-trifluoroacetic acid
C65H78F3IN24O6 — CID 163424204
Data last refreshed: (MolForge compound catalog, from PubChem)
About Tert-butyl 4-[4-amino-3-(1H-imidazo[4,5-b]pyridin-6-yl)pyrazolo[3,4-d]pyrimidin-1-yl]piperidine-1-carboxylate;tert-butyl 4-(4-amino-3-iodopyrazolo[3,4-d]pyrimidin-1-yl)piperidine-1-carboxylate;methane;3-methyl-7H-cyclopenta[b]pyridine;1-piperidin-4-yl-3-(1H-pyrrolo[2,3-b]pyridin-5-yl)pyrazolo[3,4-d]pyrimidin-4-amine;2,2,2-trifluoroacetic acid
Tert-butyl 4-[4-amino-3-(1H-imidazo[4,5-b]pyridin-6-yl)pyrazolo[3,4-d]pyrimidin-1-yl]piperidine-1-carboxylate;tert-butyl 4-(4-amino-3-iodopyrazolo[3,4-d]pyrimidin-1-yl)piperidine-1-carboxylate;methane;3-methyl-7H-cyclopenta[b]pyridine;1-piperidin-4-yl-3-(1H-pyrrolo[2,3-b]pyridin-5-yl)pyrazolo[3,4-d]pyrimidin-4-amine;2,2,2-trifluoroacetic acid (PubChem CID 163424204) has the molecular formula C65H78F3IN24O6 and a molecular weight of 1475.40 g/mol. Its IUPAC name is tert-butyl 4-[4-amino-3-(1H-imidazo[4,5-b]pyridin-6-yl)pyrazolo[3,4-d]pyrimidin-1-yl]piperidine-1-carboxylate;tert-butyl 4-(4-amino-3-iodopyrazolo[3,4-d]pyrimidin-1-yl)piperidine-1-carboxylate;methane;3-methyl-7H-cyclopenta[b]pyridine;1-piperidin-4-yl-3-(1H-pyrrolo[2,3-b]pyridin-5-yl)pyrazolo[3,4-d]pyrimidin-4-amine;2,2,2-trifluoroacetic acid.
Molecular Properties
| Compound Name | Tert-butyl 4-[4-amino-3-(1H-imidazo[4,5-b]pyridin-6-yl)pyrazolo[3,4-d]pyrimidin-1-yl]piperidine-1-carboxylate;tert-butyl 4-(4-amino-3-iodopyrazolo[3,4-d]pyrimidin-1-yl)piperidine-1-carboxylate;methane;3-methyl-7H-cyclopenta[b]pyridine;1-piperidin-4-yl-3-(1H-pyrrolo[2,3-b]pyridin-5-yl)pyrazolo[3,4-d]pyrimidin-4-amine;2,2,2-trifluoroacetic acid |
|---|---|
| PubChem CID | 163424204 |
| Molecular Formula | C65H78F3IN24O6 |
| Molecular Weight | 1475.40 g/mol |
| Exact Mass | 1474.55 |
| IUPAC Name | tert-butyl 4-[4-amino-3-(1H-imidazo[4,5-b]pyridin-6-yl)pyrazolo[3,4-d]pyrimidin-1-yl]piperidine-1-carboxylate;tert-butyl 4-(4-amino-3-iodopyrazolo[3,4-d]pyrimidin-1-yl)piperidine-1-carboxylate;methane;3-methyl-7H-cyclopenta[b]pyridine;1-piperidin-4-yl-3-(1H-pyrrolo[2,3-b]pyridin-5-yl)pyrazolo[3,4-d]pyrimidin-4-amine;2,2,2-trifluoroacetic acid |
| SMILES | C.CC(C)(C)OC(=O)N1CCC(n2nc(-c3cnc4nc[nH]c4c3)c3c(N)ncnc32)CC1.CC(C)(C)OC(=O)N1CCC(n2nc(I)c3c(N)ncnc32)CC1.Cc1cnc2c(c1)C=CC2.Nc1ncnc2c1c(-c1cnc3[nH]ccc3c1)nn2C1CCNCC1.O=C(O)C(F)(F)F |
| InChI | InChI=1S/C21H25N9O2.C17H18N8.C15H21IN6O2.C9H9N.C2HF3O2.CH4/c1-21(2,3)32-20(31)29-6-4-13(5-7-29)30-19-15(17(22)25-11-27-19)16(28-30)12-8-14-18(23-9-12)26-10-24-14;18-15-13-14(11-7-10-1-6-20-16(10)21-8-11)24-25(17(13)23-9-22-15)12-2-4-19-5-3-12;1-15(2,3)24-14(23)21-6-4-9(5-7-21)22-13-10(11(16)20-22)12(17)18-8-19-13;1-7-5-8-3-2-4-9(8)10-6-7;3-2(4,5)1(6)7;/h8-11,13H,4-7H2,1-3H3,(H2,22,25,27)(H,23,24,26);1,6-9,12,19H,2-5H2,(H,20,21)(H2,18,22,23);8-9H,4-7H2,1-3H3,(H2,17,18,19);2-3,5-6H,4H2,1H3;(H,6,7);1H4 |
| InChIKey | ZSCCOVNDRSBHCA-UHFFFAOYSA-N |
| XLogP | 10.61 |
| TPSA | 400.41 Ų |
| H-Bond Donors | 7 |
| H-Bond Acceptors | 25 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 99 |
| Complexity | — |
Lipinski Rule of Five
4 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 1475.40 |
| LogP ≤ 5 | 10.61 |
| H-Bond Donors ≤ 5 | 7 |
| H-Bond Acceptors ≤ 10 | 25 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'iodine', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 163424204 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.